ABSTRACT 1
The Wnt signaling pathway is of paramount importance for development and disease. 2
However, the tissue-specific regulation of Wnt pathway activity remains incompletely 3 understood. Here we identify FOXB2, an uncharacterized forkhead box family transcription 4 factor, as a potent activator of Wnt signaling in normal and cancer cells. Mechanistically, 5
FOXB2 induces the non-classical Wnt ligand WNT7B, which increases TCF/LEF-dependent 6 transcription without activating LRP6 or -catenin. Proximity ligation and RNA interference 7 identified YAP1, JUN, and DDX5 as transcriptional co-regulators required for FOXB2-8 dependent Wnt activation. Although FOXB2 expression is limited in adults, it is induced in 9 select cancers, particularly advanced prostate cancer. RNA-seq data analysis suggests that 10 FOXB2/WNT7B expression in prostate cancer is associated with a transcriptional program that 11 favors neuronal differentiation and decreases recurrence-free survival. Consistently, FOXB2 12
is induced during neuroendocrine transformation of LNCaP prostate carcinoma cells, and 13
conversely, FOXB2 overexpression is sufficient to induce their differentiation. Our results 14
suggest that FOXB2 is a tissue-specific Wnt enhancer that promotes prostate cancer 15 malignant transformation. 16
INTRODUCTION 17
The Wnt pathway is a major homeostatic signaling cascade in development and stem cell 18 homeostasis (Koch, 2017; MacDonald et al., 2009; Nusse and Clevers, 2017) . In the canonical 19
or -catenin-dependent signaling branch, secreted Wnt ligands engage a transmembrane 20 receptor complex consisting of Frizzled family core and LRP5/6 co-receptors, to inhibit a multi-21
protein -catenin destruction complex. Consequently, cytosolic -catenin is relieved from 22 constitutive proteasomal degradation, and induces the transcription of target genes through 23 association with TCF/LEF family transcription factors. 24
Specificity of the Wnt signaling output is achieved primarily via the differential expression of a 25 wide range of Wnt ligands and receptors, which exert overlapping but non-redundant functions 26
(MacDonald et al., 2009). Interestingly, several Wnt molecules act downstream of -catenin, 27
by synergizing with canonical Wnt ligands. For example, WNT7B elicits limited pathway 28
activation on its own, as evidenced by its inability to induce LRP6 phosphorylation and -29 catenin stabilization to any substantial degree (Alok et al., 2017) . However, WNT7B strongly 30 co-operates with other ligands, primarily Wnt1, in driving TCF/LEF-dependent gene 31
transcription. The mechanism of WNT7B-dependent pathway activation is unclear, but it 32 requires additional co-receptors, namely RECK and GPR124 (Alok et al., 2017; Vallon et al., 33 2018; Vanhollebeke et al., 2015) . The expression of WNT7B and its co-receptors is largely 34 restricted to specific tissues, especially the developing brain, where they contribute to blood-35
brain barrier formation and maintenance through activation of Wnt/-catenin signaling ( 
Molecular cloning 70
Expression constructs were generated by restriction cloning of full-length cDNA from an in-71
house intestinal epithelial cell library into a pCS2+ vector with N-terminal Flag or V5 tag. For 72 stable expression, cDNAs were subcloned into a pcDNA3 vector, and transfectants were 73 isolated by G418 selection. Point and truncation mutants were generated by restriction cloning 74
and PCR-based mutagenesis, using high fidelity Q5 polymerase (New England Biolabs, 75
Ipswich, US). All plasmids were validated by partial sequencing. 76
Plasmid and siRNA transfection 77
Cells were transfected by calcium phosphate precipitation (293T only), or lipofection using 78
Lipofectamine 3000 (LNCaP) or 2000 (all other cells) (Thermo Fisher, Waltham, USA). siRNAs 79
were purchased from Integrated DNA Technologies (IDT, Skokie, USA) and Thermo Fisher. 80
Detailed plasmid information can be found in Supplemental Table 1 . 81
Antibodies and reagents 82
Primary antibodies were purchased from the following companies. Sigma Aldrich ( Arbor, USA). 91
Luciferase assays 92
The TOPflash -catenin/TCF reporter assay was performed essentially as described (Veeman 93 et al., 2003) . The WNT7B reporter was generated by replacing the TOPflash TCF binding 94 domains with a 1kb enhancer region from the human WNT7B gene. Luciferase activity was 95 measured using a Firefly luciferase glow assay kit (Thermo Fisher). Data were normalized to 96 the average intensity of identically treated FOPflash control, performed in triplicate. 97
Quantitative real-time PCR 98
qPCR was performed using standard protocols. In brief, RNA was extracted using a Qiagen 99
RNeasy Mini kit (Hilden, Germany), and reverse transcribed with a Thermo Fisher cDNA 100 synthesis kit. cDNA was amplified using validated custom primers, with SYBR green dye. Data 101
were acquired on a Bio-Rad CFX96 Touch thermocycler (Hercules, USA), and normalized to 102 HPRT1 control. 103
Immunoblotting 104
Immunoblotting was performed using standard protocols. In brief, proteins were extracted in 105 NP-40 containing lysis buffer with protease inhibitors, and boiled in Laemmli sample buffer. 106
Subcellular fractionation was done with the REAP method (Suzuki et al., 2010) . Samples were 107 separated on polyacrylamide gels, transferred onto nitrocellulose membranes, and incubated 108 in blocking buffer. Primary antibodies were detected using near infrared (NIR) fluorophore-109 labeled secondary antibodies. Blots were scanned on a LI-COR CLx imager (Lincoln, USA). 110
Consumables were purchased from Bio-Rad and LI-COR. 111
Co-immunoprecipitation 112
Co-IP was performed essentially as before (Koch et al., 2015) , with minor modifications. Briefly, 113
constructs were expressed in HCT116 cells for 48 hours, and nuclei were isolated using the 114 REAP method. Nuclei were resuspended in IP lysis buffer (TBS pH 7.5, 1mM MgCl2, 2mM β-115 mercaptoethanol, 10mM sodium pyrophosphate, 1% v/v Triton X-100, protease inhibitors) and 116 sonicated. Samples were precleared with protein A/G beads (Santa Cruz Biotechnology) for 1 117 hour, and incubated with anti-Flag antibody for 2 hours at 4°C with end-over-end rotation. 118
Protein A/G beads were added, and samples were incubated overnight at 4°C with end-over-119 end rotation. After repeated washes in IP wash buffer (TBS pH 7.5, 2mM β-mercaptoethanol, 120
1% v/v Triton X-100), beads were boiled in Laemmli sample buffer and analyzed by 121
immunoblotting. 5% of the initial nuclear lysate was saved for input control. 122
Immunocytochemistry 123
Immunocytochemistry was performed essentially as before (Koch et al., 2015) . In brief, cells 124
were fixed with 4% paraformaldehyde, permeabilized with Triton X-100 containing buffer, and 125 blocked with bovine serum albumin. Primary antibodies were detected using fluorophore-126 labeled secondary antibodies (Thermo Fisher). Samples were mounted in Prolong Glass 127
Antifade (Thermo Fisher) with Hoechst 33342 or NucBlue nuclear counterstain. Images were 128 acquired on a Zeiss LSM 800 confocal microscope with Airyscan (Oberkochen, Germany), or 129 a Nikon E800 epifluorescence microscope (Amstelveen, Netherlands). Fluorescence intensity 130 on a per-cell level was measured in ImageJ 1.52i (National Institutes of Health, USA). 131
BioID and mass spectrometry 132
The BioID assay was performed essentially as described (Roux et al., 2012) . N-terminal BirA-133
FOXB2 and BirA plasmids were transfected into 293T cells using Lipofectamine 2000. After 6 134 h of transfection, cells were treated with 50 µM biotin, and incubated for 24 h at 37ºC, 5% CO2. 135
Cells were lysed in RIPA buffer for 1 h at 4 ºC with end-over-end rotation. Pre-washed 136 streptavidin beads (GE Healthcare, USA) were added to the cell lysate and incubated for 3 h 137 at 4ºC with end-over-end rotation. The beads were washed four times with 50 mM ammonium 138 bicarbonate (NH4HCO3). Enzymatic digestion was carried out by adding 100 µl of freshly 139 prepared 10 ng/µl proteomics grade trypsin (Thermo Fisher) in 50 mM NH4HCO3 to the beads, 140 and samples were incubated overnight at 37ºC with end-over-end rotation. The digested 141 samples were dried by vacuum centrifugation. 142
BioID experiments were performed in triplicates using an Easy nano LC II HPLC interfaced 143 with a nanoEasy spray ion source (Thermo Fisher) connected to an Orbitrap Velos Pro mass 144 spectrometer (Thermo Fisher). The peptides were loaded on a NS-MP-10 Biosphere C18 145 column 2 cm (100 μm inner diameter, packed with 5 μm resin) and the chromatographic 146
separation was performed at RT on a 10.1 cm (75 μm inner diameter) NS-AC-10-C18 column 147 packed with 5 μm resin (NanoSeperations, Netherlands). The nano HPLC was operating at 148 300 nl/min flow rate with a linear gradient of solvent B (0.1% (v/v) formic acid in acetonitrile) in 149 solvent A (0.1% (v/v) formic acid in water) for 60 min. Quantification of the analyzed data was performed with Scaffold 4 (Proteome Software, 161
Portland, USA) using total spectral count. 162
In-situ proximity ligation 163
Proximity ligation was performed using Duolink PLA assay reagents according to the supplier's 164 guidelines (Sigma Aldrich). In brief, cells were transiently transfected with V5-FOXB2 and Flag-165 tagged proteins of interest, and antigens were detected with rabbit anti-FOXB2 and mouse 166
anti-Flag antibodies. Following addition of matched PLA probes, rolling circle amplification 167 proceeded for 90 minutes at 37°C. Identically transfected cells were processed for regular 168 immunocytochemistry using the same antibodies, to control for protein expression and 169
localization. An empty eGFP vector at 1/10 th the total plasmid amount was added in PLA 170 assays to identify transfected cells. 171
Public dataset analyses 172
The results in this study are in large part based upon data generated by the TCGA Research The context-dependent regulation of canonical Wnt signaling is incompletely understood. In 194 an effort to discover novel pathway regulators, we performed a gain-of-function screen by co-195
expressing Flag-tagged proteins of interest with a -catenin/TCF luciferase reporter (TOPflash) 196
in HEK 293T cells. We identified the uncharacterized transcription factor FOXB2 as a 197
candidate Wnt activator (Fig. 1A, B ). FOXB2 strongly promoted TOPflash activity, at least to 198 the same extent as the known Wnt activator FOXQ1 (Peng et al., 2015) , and potently 199 synergized with the pathway agonists Wnt3a/R-spondin 3 (Fig. 1B) . Moreover, FOXB2 induced 200
TOPflash activity in HCT116 and SW48 colorectal cancer cells, which harbor activating -201 catenin mutations and are thus largely unresponsive to further pathway activation (Fig. 1C) . Of 202 note, the most closely related FOX family member, FOXB1, as well as other tested FOX 203
proteins, did not activate Wnt signaling in these assays ( Fig. S1A, and data not shown). 204 bind -catenin or co-localize with nuclear -catenin ( Fig. S1D, E) . Since TOPflash is an artificial 213
Wnt reporter, we also tested the regulation of the prototypical Wnt target gene AXIN2 by qPCR 214 (Fig. 1E ). Consistent with results from the TOPflash assays, FOXB2 induced AXIN2 215 expression alone as well as in synergy with Wnt3a/R-spondin 3. Surprisingly, partial AXIN2 216 induction by FOXB2 was also observed in -catenin deficient cells, and Wnt3a/R-spondin 3 217 synergy was retained despite no effect of these ligands by themselves. Collectively, these data 218 identify FOXB2 as a novel Wnt pathway activator upstream of -catenin. 219 220
FOXB2 induces WNT7B to activate TCF-dependent transcription 221
The most likely explanation for the above observations is that FOXB2 activates Wnt signaling 222
by inducing one or more canonical Wnt ligands. To test this hypothesis, we first treated FOXB2-223 transfected 293T cells with porcupine inhibitor LGK974, which blocks the release of 224 endogenous Wnts ( Fig. 2A ).
LGK974 strongly attenuated FOXB2-induced Wnt signaling. This 225 effect was more pronounced in cells with additional exogenous R-spondin 3 compared to cells 226 treated with Wnt3a conditioned media, suggesting that FOXB2 induces Wnt ligands rather than 227 R-spondins. Consistently, iCRT14, which inhibits -catenin/TCF interaction, also reduced 228
FOXB2-dependent TOPflash activation, and this effect was less pronounced in the presence 229 of exogenous Wnt3a (Fig. S2) . 230
To explore these observations further, we examined the regulation of all 19 Wnt ligands by 231 FOXB2 (Fig. 2B ). Expression of FOXB2 in 293T cells strongly induced multiple Wnts, 232
particularly WNT1, WNT6, WNT7B, and WNT9B. Since several of these ligands can activate 233 the canonical Wnt signaling branch, we next examined LRP6 phosphorylation and -catenin 234 stabilization, which are early hallmarks of pathway activation (Fig. 2C) induced Wnt signaling, we interrupted this pathway branch by RNA interference (Fig. 2D ). 240
Indeed, depletion of WNT7B or its co-receptors RECK and GPR124 strongly attenuated 241
TOPflash activation by FOXB2. Finally, to test whether FOXB2 directly regulates WNT7B, we 242 generated a luciferase reporter construct containing an intronic WNT7B enhancer region (Fig.  243  2E) . FOXB2, but not FOXB1, activated this reporter, and again synergized with Wnt3a/R-244 spondin 3. We conclude that FOXB2 activates Wnt/TCF independently of -catenin, by directly 245 engaging a non-classical WNT7B/RECK/GPR124 signaling module. 246 247
Protein-DNA and protein-protein interaction shape FOXB2-dependent Wnt signaling 248
The DNA-binding forkhead box is highly conserved across FOX family proteins (Li and Tucker, 249 1993) ( Figure S3 ). Nonetheless, despite exceedingly high sequence similarity between e.g. Wnt signaling, we first generated a series of truncations and point mutants (Fig. S4A) . 255
Importantly, all truncation constructs exhibited strongly reduced activity in TOPflash assay, 256
including deletion mutants missing the unique central and C-terminal regions (Fig. 3A) . 257
Moreover, a FOXB2 point mutant that is unable to bind DNA (P14A/P15A, see (Li and Tucker, 258 1993)) was completely inert in this assay. In contrast, mutation of a putative engrailed 259 homology (EH1) motif (G277A) had no effect on TOPflash activation. Based on these results, 260
we tested the ability of select FOXB2 mutants to induce WNT7B expression ( Fig. 3B ).
261
Consistent with the TOPflash data, WNT7B induction was essentially blocked in FOXB2 262 constructs lacking either the conserved N-terminal or unique C-terminal domain. 263
264

FOXB2-dependent Wnt signaling is controlled by transcriptional co-regulators 265
Our data so far suggested that activation of Wnt signaling by FOXB2 requires interaction with 266 other proteins. In order to identify possible FOXB2 interactors, we generated an N-terminal 267
BirA-FOXB2 fusion construct for proximity labeling (Roux et al., 2012) , which retained full 268 activity in TOPflash (Fig. S4B-D) . Mass spectrometry following streptavidin pull-down of pulse-269 labeled proteins revealed numerous candidates that were enriched compared to free BirA 270 control, with high consistency across multiple experiments (Fig. 4A ). Statistical analysis 271 narrowed the initial list down to 95 high confidence hits. These included several candidates 272 that have previously been linked to Wnt signaling, such as YAP1 and JUN (Fig. 4B ). As 273 expected, gene ontology analysis of high confidence interactors showed that putative FOXB2-274 associated proteins are primarily involved in the regulation of gene transcription and mRNA 275 splicing ( Fig. 4C , and Supplemental Table 2 ). In contrast, and in agreement with our earlier 276 observations, we did not pull down -catenin in any experiment. 277
We validated the BioID data by in-situ proximity ligation (Fig. 4D) The only major expression site of mammalian FOXB2 is the developing brain, particularly the 288 thalamus and hypothalamus (Kaestner et al., 1996) . In adult mice, limited Foxb2 expression 289 was observed in some tissues, specifically the brain, thymus, ovary, and testis (Kaestner et 290 al., 1993) . Although analysis of public gene expression databases showed that FOXB2 levels 291 are exceedingly low in normal tissues, we found that it is induced in some cancers, including 292 thymomas, ovarian cancer, and testicular germ cell cancer (Fig. S5 ). In particular, we observed 293 that FOXB2 transcript levels were frequently increased in prostate cancer. Here, FOXB2 294
amplification was detected mainly in aggressive, castration-resistant and neuroendocrine 295 tumors (Fig. 5A) . On the molecular level, highest FOXB2 expression was observed in the 296 iCluster 2 prostate cancer subtype (Cancer Genome Atlas Research, 2015), which is 297 predominantly characterized by ERG fusions, as well as PTEN and TP53 mutation (Fig. S6A ).
298
Of note, these genetic lesions are individually associated with prostate cancer progression and 299
poor prognosis, further suggesting that FOXB2 is specifically induced in aggressive cancers. 300
Subsequent data analysis revealed that FOXB2 upregulation in prostate cancer was 301 associated with significantly increased WNT7B levels (Fig. 5B) , and that WNT7B transcript 302 levels were highest in iCluster 2 tumors (Fig. S6B) . Importantly, genome-wide analysis of 303 prostate cancer RNA-seq data showed a high degree of correlation between the FOXB2 and 304
WNT7B-associated transcriptome, suggesting that they act in the same pathway in cancer 305 (Fig. 5C ). Consistent with this notion, the WNT7B receptors RECK and GPR124, but not 306 WNT7B itself, are frequently co-amplified with FOXB2 in castration-resistant and 307 neuroendocrine prostate cancers (Fig. 5D ). In contrast, FOXB1 and FOXA2 were not 308 associated with increased WNT7B expression ( Fig. S6C) . 309
Gene ontology analysis of the most strongly FOXB2/WNT7B co-correlated genes in prostate 310 cancer revealed that positively correlated genes are primarily involved in neurogenesis and 311 cell migration (Fig. 5E ), which is consistent with the anticipated physiological role of Foxb2 in 312 brain development (Kaestner et al., 1996) . Conversely, negatively correlated genes mainly 313 control small molecule metabolism and metal ion transport, required for normal prostate 314 function (Fig. S6D ). Taken together, these data suggest that FOXB2, presumably via WNT7B, 315 may regulate a transcriptional program involved in the neuronal differentiation of prostate 316 cancer cells, a feature that is linked to cancer progression and poor prognosis (Parimi et al., 317 2014) . 318
In support of this hypothesis, we observed that both FOXB2 and WNT7B are associated with 319 worse recurrence-free survival (RFS) in prostate cancer (Fig. S7A, B) , albeit non-significantly 320
in the case of FOXB2. Moreover, numerous FOXB2/WNT7B correlated genes are individually 321 associated with altered RFS in prostate cancer, and remarkably, they cluster in a near-binary 322 manner ( Fig. S7C) : genes that are positively correlated with FOXB2 preferentially predict 323 worse survival, whereas negatively correlated genes are linked to better survival. Indeed, we 324
observed that a gene signature consisting of the top 50 FOXB2/WNT7B negatively correlated 325
genes was strongly associated with improved RFS in iCluster 2-type prostate cancer (Fig. 5F,  326 and Fig. S7D, E) LNCaP cells (Fig. 6A) . Although results were less consistent than in other cell lines, 335 presumably due to low transfection efficiency, we observed robust activation of the TOPflash 336
reporter by FOXB2, at least in the presence of exogenous Wnt3a and R-spondin 3. 337
We next asked whether FOXB2 could cause prostate cancer neuroendocrine differentiation. 338
Transient transfection of FOXB2 in LNCaP cells for up to 4 days did not induce any obvious 339
phenotypical changes (Fig. 6B ). However, stable FOXB2 expression resulted in a rapid, near-340 complete growth arrest following selection in G418-containing media, which precluded us from 341
propagating these cells. Remaining cells adopted a neuron-like morphology with compact body 342
and very long protrusions. Importantly, this phenotype is consistent with LNCaP 343 neuroendocrine differentiation induced by e.g. androgen depletion and Wnt11 overexpression 344
(Uysal-Onganer et al., 2010). 345
We validated this observation by investigating the expression of differentiation marker neuron-346 specific enolase (NSE) (Fig. 6C, D) . After four days, FOXB2-expressing cells displayed slightly 347 but significantly elevated NSE levels compared to non-transfected cells in the same sample. 348
Moreover, stable expression of FOXB2 substantially increased NSE expression, consistent 349 with neuroendocrine differentiation. Conversely, we found that in empty vector transfected 350
control LNCaP subjected to the same G418 selection protocol, some cells underwent 351 spontaneous differentiation, albeit at a lower rate than FOXB2 transfected cells (Fig. 6E) . Consequently, Wnt7a/Wnt7b double knock-out mice die around E12.5 due to fatal cerebral 416
hemorrhaging. We find that FOXB2 strongly induces WNT7B, and to a lesser extent WNT7A, 417
at least in 293T cells. Thus, FOXB2 may be a rheostat of Wnt signaling activity and 418 angiogenesis in the developing brain. 419
In summary, we report the first molecular characterization of the cryptic forkhead box 420 transcription factor FOXB2. We identify FOXB2 as a potent activator of Wnt/TCF signaling in 421 normal and cancer cells. Given the putative roles of FOXB2 in neurogenesis and the 422 neuroendocrine differentiation of advanced prostate cancer, it is possible that FOXB2 controls 423 both processes through a common, presumably WNT7B-dependent signaling mode, which is 424 aberrantly re-activated in cancer. We believe that further exploration of the FOXB2/WNT7B-425 associated transcriptome may uncover new therapeutic vulnerabilities in rare, aggressive 426 cancers. 427 reagents. We also thank all investigators who have made materials and data available through 430 public repositories. Technical support from the microscopy and mass spectrometry core 431
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Foundation. or stabilize -catenin. Where indicated, cells were treated with Wnt3a conditioned media for 6 598 hours. (D) Depletion of WNT7B or its co-receptors RECK and GPR124 by RNA interference 599 attenuated FOXB2-dependent TOPflash activation in 293T cells. Note that these siRNAs had 600 essentially no effect on basal Wnt signaling. (E) Luciferase-based WNT7B enhancer assay in 601
293T cells. FOXB2, but not FOXB1, activated the WNT7B reporter in synergy with Wnt3a/R-602 spondin 3. 603 TOPflash assay in the presence of 10µM iCRT14 showed attenuated pathway activation by 670
FOXB2. 671 Supplemental Table 2, containing high confidence FOXB2 interactors and their associated  723 gene ontology analysis, can be found in the online supplemental material. 724
